VR-based Remote Rehabilitation for Pediatric ABI
Virtual Reality Based Rehabilitation of Vestibular and Oculomotor Function for Pediatric ABI in a Home Setting
1 other identifier
interventional
2
1 country
1
Brief Summary
The primary objective of this study is to evaluate the feasibility and effectiveness of an at-home program of VR-based vestibular and oculomotor rehabilitation on improving postural stability, ocular motility and activities of daily living for children with mild to severe ABI
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2021
CompletedFirst Posted
Study publicly available on registry
September 22, 2021
CompletedStudy Start
First participant enrolled
October 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedDecember 12, 2023
December 1, 2023
1.2 years
August 25, 2021
December 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Vestibular Oculomotor Motor Screening (VOMS)
Symptoms scoring from 0 (none) to 10 (severe)
6 months
Pediatric Vestibular Symptom Questionnaire (PVSQ)
Score ranging from 0 (never) to 33 (most of the time) with a 4-Likert scale
6 months
Convergence Insufficiency Symptom Survey (CISS)
Score ranging from 0 (never) to 56 (Always) with a 5-Likert scale
6 months
Dizziness Handicap Inventory (DHI)
Score ranging from 0 (none) to 100 (severe) with a 3-Likert scale
6 months
Dizziness Handicap Inventory for patients caregivers (DHI-PC)
Score ranging from 0 (none) to 100 (severe) with a 3-Likert scale
6 months
Pediatric Quality of Life Inventory (PEDSQL)
Score ranging from 0 (worst) to 100 (best) with a 5-Likert scale
6 months
Modified Clinical Test of Sensory Interaction in Balance (mCTSIB)
Time score ranging from 0 (unable to complete) to 120 (completed successfully) in one of three 30-seconds trials and four conditions
6 months
Berg Balance Scale (Berg)
Score ranging from 0 (lowest level of function) to 56 (highest level of function) with a 5-Likert scale
6 months
Study Arms (1)
Study
EXPERIMENTALExercises
Interventions
LibraVR is a standalone VR-based rehabilitation software for use in physiotherapy. It is designed to work with standard off-the-shelf hardware that is tested and approved for use in conjunction with the software. LibraVR system consists of the software (LibraVR Clinic) running on a PC (database of patients, creation of protocols, uploading protocols to mobile), and the LibraVR Mobile APP that runs on commercial mobile smartphones embedded in a lightweight cardboard or plastic VR viewer that the child wears as they would eyeglasses. The software displays a range of immersive VR exercises.
Eligibility Criteria
You may qualify if:
- They are ALYN patients undergoing physiotherapy for mild to severe ABI;
- They experience symptoms of vestibular function such as vertigo, postural instability, or impaired ocular motility;
- They are between the ages of 8 and 18;
- The time since injury/event is between 10 days and 1 year after the injury/event;
- They are able to maintain stable and dynamic positioning of the head;
- They able to walk with or without assistive equipment, or use a wheelchairs with no need for head support, defined by a LSS (level of sitting scale) score of 3 or greater (scale range: 1-8);
- Are able to understand basic instructions;
- Have sufficient visual acuity and visual field to identify and track mid-size objects on a screen.
You may not qualify if:
- Psychological, neurological or cognitive disorders which could impede participation, such as a history of epileptic seizures;
- Untreated benign paroxysmal positional vertigo (BPPV);
- Are in early post-operative stages (to avoid risk of bleeding or cerebrospinal fluid leak);
- Hearing impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ALYN Hospital Pediatric and Adolescent Rehabilitation Center
Jerusalem, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Naomi Gefen
ALYN Hospital Pediatric and Adolescent Rehabilitation Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2021
First Posted
September 22, 2021
Study Start
October 15, 2021
Primary Completion
December 15, 2022
Study Completion
April 1, 2023
Last Updated
December 12, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share